DMAAR

Conviction 25FinancialsScan · Mon, Aug 10, 2026

Bearish marubozu

DMAAR$0.1601+6.73%

ResistanceSupportVol 14

Vol MA14 39.24K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Drugs Made In America Acquisition Corp.Blank Checks

Price0.1601

Change+6.73%

Gap+9.93%

Rel volume0.01×

Avg volume79.61K

Avg $ vol12.18K

SMA 200.1430

SMA 500.1129

SMA 2000.1166

Price vs 50+41.76%

Price vs 200+37.34%

MA stackmixed

50/200 cross—

Supertrendup · 0.0974

RSI (14)56

MACD hist-0.00

MACD crossbear · 1d

Stoch %K / %D38 / 40

ADX (14)12

+DI / −DI38 / 31

RSI divergence—

MACD divergence—

ATR %+15.22%

ADR %9.87%

52w high0.2300

52w low0.0000

From 52w high-30.39%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width109.20%

%B0.61

Donchian pos76.24%

Donchian high0.2100

Donchian low0.0000

AVWAP (52w high)0.1147

vs AVWAP high+39.60%

AVWAP (52w low)0.1177

vs AVWAP low+36.00%

OBV trendFlat

Chaikin MF (20)0.01

Today vs 20d0.01×

Avg vol (14d)39.24K

Avg vol (20d)79.61K

Avg $ vol (20d)12.18K

Market cap3.89M

RS 3m (vs SPY)-5.03%

RS 6m (vs SPY)-6.97%

RS line new highNo

Trend template2/8

Technical rank87.0

1 week-5.60%

1 month+52.48%

3 months+14.36%

6 months+23.15%

1 year-11.06%

YTD—

P/E0.65

P/B-0.53

P/S—

P/FCF—

EPS-0.0300

Div yield—

ROE-80.53%

ROA2.45%

Debt/Eq—

Current0.03

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3.87M

Revenue—

Net income1.97M

Gross profit—

Free cash flow—

IndustryBlank Checks

ExchangeNasdaq

Shares out—

Employees—

ListedTue, Feb 25, 2025

Free float24.28M

Float %100.0%

Short interest6.47K

Days to cover0.2d

Short volume25.9%

Squeeze score1 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction25 / 100

Pattern quality—

Tech rank87.0 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish marubozu

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DMAAR

All disclosures →

No recent disclosed trades by Congress in DMAAR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DMAAR

No recent insider (Form 4) filings in DMAAR. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DMAAR

EDGAR →

No recent SEC filings on file for DMAAR.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.